Pharma Research and Development Penzberg, Roche Diagnostics GmbH, Penzberg, Germany.
PLoS One. 2012;7(1):e30295. doi: 10.1371/journal.pone.0030295. Epub 2012 Jan 17.
The degradation of proteins by asparagine deamidation and aspartate isomerization is one of several chemical degradation pathways for recombinant antibodies. In this study, we have identified two solvent accessible degradation sites (light chain aspartate-56 and heavy chain aspartate-99/101) in the complementary-determining regions of a recombinant IgG1 antibody susceptible to isomerization under elevated temperature conditions. For both hot-spots, the degree of isomerization was found to be significantly higher than the deamidation of asparagine-(387, 392, 393) in the conserved CH3 region, which has been identified as being solvent accessible and sensitive to chemical degradation in previous studies. In order to reduce the time for simultaneous identification and functional evaluation of potential asparagine deamidation and aspartate isomerization sites, a test system employing accelerated temperature conditions and proteolytic peptide mapping combined with quantitative UPLC-MS was developed. This method occupies the formulation buffer system histidine/HCl (20 mM; pH 6.0) for denaturation/reduction/digestion and eliminates the alkylation step. The achieved degree of asparagine deamidation and aspartate isomerization was adequate to identify the functional consequence by binding studies. In summary, the here presented approach greatly facilitates the evaluation of fermentation, purification, formulation, and storage conditions on antibody asparagine deamidation and aspartate isomerization by monitoring susceptible marker peptides located in the complementary-determining regions of recombinant antibodies.
蛋白质的天冬酰胺脱酰胺和天冬氨酸异构化降解是重组抗体的几种化学降解途径之一。在这项研究中,我们在重组 IgG1 抗体的互补决定区中鉴定出两个易受高温条件下异构化影响的溶剂可及的降解位点(轻链天冬氨酸-56 和重链天冬氨酸-99/101)。对于这两个热点,异构化的程度被发现明显高于先前研究中鉴定出的溶剂可及且对化学降解敏感的保守 CH3 区域中天冬酰胺-(387、392、393)的脱酰胺化。为了减少同时鉴定和功能评估潜在天冬酰胺脱酰胺和天冬氨酸异构化位点的时间,开发了一种采用加速温度条件和蛋白水解肽图谱结合定量 UPLC-MS 的测试系统。该方法利用制剂缓冲液系统组氨酸/HCl(20 mM;pH 6.0)进行变性/还原/消化,并消除了烷基化步骤。达到的天冬酰胺脱酰胺和天冬氨酸异构化程度足以通过结合研究来识别功能后果。总之,所提出的方法通过监测位于重组抗体互补决定区的易受影响的标记肽,极大地促进了对抗体天冬酰胺脱酰胺和天冬氨酸异构化的发酵、纯化、制剂和储存条件的评估。